RAC 2.00% $1.79 race oncology ltd

Ann: First Patient Dosed in Phase 1b/2 AML Trial, page-243

  1. 637 Posts.
    lightbulb Created with Sketch. 290
    Have we received an update on the status of recruitment?

    First patient recruited 06.08.2021 and per below they anticipate timeline of it being completed by March 2023.

    Understand we will not receive updates until the dose esclation has finished.

    Was there anything mentioned at the AGM on the progress?



    https://hotcopper.com.au/data/attachments/4874/4874280-69d72fa86afa43e45f9a68370a2563b1.jpg

 
watchlist Created with Sketch. Add RAC (ASX) to my watchlist
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.